Literature DB >> 26954465

Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in Canada.

Melanie Drolet1, Shelley L Deeks2, Erich Kliewer3, Grace Musto4, Pascal Lambert4, Marc Brisson5.   

Abstract

BACKGROUND: Human papillomavirus (HPV) vaccination programs have been implemented in more than 50 countries. These programs offer tremendous promise of reducing HPV-related disease burden. However, failure to achieve high coverage among high-risk groups may mitigate program success and increase inequalities. We examined sociodemographic inequalities in HPV vaccination coverage in 4 Canadian provinces (Quebec (QC), Ontario (ON), Manitoba (MB), British Columbia (BC)).
METHODS: We obtained annual HPV vaccination coverage of pre-adolescent girls at provincial and regional levels, from the start of programs to 2012/2013. Regions refer to administrative areas responsible for vaccine implementation and monitoring (there are 18/36/10/16 regions in QC/ON/MB/BC). We obtained regions' sociodemographic characteristics from Statistics Canada Census. We used univariate weighted linear regression to examine the associations between regions' sociodemographic characteristics and HPV vaccination coverage.
RESULTS: Provincial HPV vaccination coverage is generally high (QC:78%; ON:80%; MB:64%, BC:69%, 2012/13). QC had the highest provincial vaccination coverage since the program start, but had the greatest inequalities. In QC, regional HPV vaccination coverage was lower in regions with higher proportions of socially deprived individuals, immigrants, and/or native English speakers (p<0.0001). These inequalities remained stable over time. Regional-level analysis did not reveal inequalities in ON, MB and BC.
CONCLUSION: School-based HPV vaccination programs have resulted in high vaccination coverage in four Canadian provinces. Nonetheless, high overall coverage did not necessarily translate into equality in coverage. Future work is needed to understand underlying causes of inequalities and how this could impact existing inequalities in HPV-related diseases and overall program success.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Health inequalities; Human papillomavirus (HPV); Immunization

Mesh:

Substances:

Year:  2016        PMID: 26954465     DOI: 10.1016/j.vaccine.2016.02.069

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation.

Authors:  Steven Habbous; Karen P Chu; Harold Lau; Melissa Schorr; Mathieos Belayneh; Michael N Ha; Scott Murray; Brian O'Sullivan; Shao Hui Huang; Stephanie Snow; Matthew Parliament; Desiree Hao; Winson Y Cheung; Wei Xu; Geoffrey Liu
Journal:  CMAJ       Date:  2017-08-14       Impact factor: 8.262

2.  HPV sampling options for cervical cancer screening: preferences of urban-dwelling Canadians in a changing paradigm.

Authors:  G D Datta; M H Mayrand; S Qureshi; N Ferre; L Gauvin
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

3.  Association between mothers' screening uptake and daughters' HPV vaccination: a quasi-experimental study on the effect of an active invitation campaign.

Authors:  Francesco Venturelli; Flavia Baldacchini; Cinzia Campari; Cinzia Perilli; Maria Grazia Pascucci; Alba Carola Finarelli; Luigi Moscara; Paolo Giorgi Rossi
Journal:  BMJ Open       Date:  2017-09-25       Impact factor: 2.692

4.  COVID-19 Vaccine Uptake in Southeastern Ontario, Canada: Monitoring and Addressing Health Inequities.

Authors:  Megan A Carter; Suzanne Biro; Allison Maier; Clint Shingler; T Hugh Guan
Journal:  J Public Health Manag Pract       Date:  2022-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.